<scp>HIV</scp> and hepatitis <scp>C</scp> virus coinfection in <scp>C</scp>anada: challenges and opportunities for reducing preventable morbidity and mortality

Abstract

We observed excessive morbidity and mortality in this HIV/HCV-coinfected population in care. Over 50% of observed deaths may have been preventable. Interventions aimed at improving social circumstances, reducing harm from drug and alcohol use and increasing the delivery of HCV treatment in particular will be necessary to reduce adverse health outcomes among HIV/HCV-coinfected persons.